Uniunea Europeană - română - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran, vacc.tiparnmcovid-19(cu nucleozide modificate) - conc. pt. dispersie injectabila - 10 µg/doza - vaccinuri virale alte vaccinuri virale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran, vacc.tiparnmcovid-19(cu nucleozide modificate) - dispersie injectabila - 30 µg/doza - vaccinuri virale alte vaccinuri virale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran, vacc.tiparnmcovid-19(cu nucleozide modificate) - conc. pt. dispersie injectabila - 30 µg/doza - vaccinuri virale alte vaccinuri virale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran, vacc.tiparnmcovid-19(cu nucleozide modificate) - conc. pt. dispersie injectabila - 3µg/doza - vaccinuri virale alte vaccinuri virale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran/riltozinameran vacc.tiparnmcovid-19(cu nucleozide modificate) - dispersie injectabila - 15µg/15µg/doza - vaccinuri virale alte vaccinuri virale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran, vacc.tiparnmcovid-19(cu nucleozide modificate) - conc. pt. dispersie injectabila - 3µg/doza - vaccinuri virale alte vaccinuri virale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biontech manufacturing gmbh/ pfizer manufacturing - germania/belgia - tozinameran/famtozinameran vacc.tiparnmcovid-19(cu nucleozide modificate) - dispersie injectabila - 15µg/15µg/doza - vaccinuri virale alte vaccinuri virale

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

biontech manufacturing gmbh - combinaţie - dispersie injectabilă - 30 mcg/doză

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

biontech manufacturing gmbh - combinaţie - concentrat pentru dispersie injectabilă - 30 mcg/doză